About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 257 record(s)
Req # A-2021-000650
Adverse Reaction Reports (AERs) for CYCLOPHOSPHAMIDE. Report numbers: 918864, 918869, 918929.Organization: Health Canada
September 2021
Req # A-2021-000756
Health Canada’s total spending on translation services under Request for Standing Offers (RFSO), Translation Services, Requisition Reference no. 1000211711 between July 1st 2019 to June 30 2020 and between July 1st 2020 and June 30th 2021. Detailed…Organization: Health Canada
September 2021
Req # A-2021-000825
Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE. Report number: E2B_03506859.Organization: Health Canada
September 2021
Req # A-2019-001824
Adverse Drug Reaction (ADR). Report number: E2B_02764686.Organization: Health Canada
August 2021
Req # A-2020-001344
Adverse Reaction Reports (AERs) for SODIUM AUROTHIOMALATE. Report numbers: E2B_03070468, E2B_03071551, E2B_03135772.Organization: Health Canada
August 2021
Req # A-2020-001486
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100273-135, 2020 Public Health Agency of Canada Awards Launch.Organization: Health Canada
August 2021
Req # A-2020-001551
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-116013-691, Industry Proposal for Food Advertising Restrictions to Children.Organization: Health Canada
August 2021
Req # A-2021-000040
Adverse Drug Reaction (ADR) for GENVOYA. Report number: E2B_03707140.Organization: Health Canada
August 2021
Req # A-2021-000181
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03757230.Organization: Health Canada
August 2021
Req # A-2021-000182
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03744567.Organization: Health Canada
August 2021